Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
XETRA:DMP
Price:
33.5 EUR
4.36%
Market Closed
Updated:
May 4, 2024
Dermapharm Holding SE
Net Income (Common)
|
Dermapharm Holding SE
Net Income (Common) Peer Comparison
Comparables:
ATAI
BAYN
MRK
93M1
PSG
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Income (Common)
€62.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Income (Common)
-$40.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Net Income (Common)
-€2.9B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Net Income (Common)
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Net Income (Common)
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Net Income (Common)
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Dermapharm Holding SE's Net Income (Common)?
Net Income (Common)
62.4m
EUR
62.4m
EUR
Based on the financial report for Dec 31, 2023, Dermapharm Holding SE's Net Income (Common) amounts to 62.4m EUR.
What is Dermapharm Holding SE's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-4%
-4%
Over the last year, the Net Income (Common) growth was -54%. The average annual Net Income (Common) growth rates for Dermapharm Holding SE have been -10% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
